Orphan designation: bortezomib Treatment of patients with light chain (AL) amyloidosis, 08/11/2023 Positive | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 1 February 2024 - 15:55

Orphan designation: bortezomib Treatment of patients with light chain (AL) amyloidosis, 08/11/2023 Positive

Link:

https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-23-2848

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters